Medicare, Medicaid Anti-fraud Provisions Set to Expand
The heat is being turned up on Medicare and Medicaid fraud this week with the release of new federal rules designed to detect fraud earlier and the introduction of proposed legislation that would strengthen the authority of the Department of Health and Human Services (HHS) to ban corporate executives from doing business with Medicare if they are convicted of fraud.
The new regulations, which will appear in the Sept. 23 Federal Register, would subject certain service providers and suppliers to fingerprinting, criminal background checks, unscheduled or unannounced visits, and stopped payments if credible fraud allegations are detected.
According to the new rules, service providers refer to healthcare entities that furnish services primarily payable under Medicare Part A, such as hospitals, home health agencies (including home health agencies providing services under Part B), hospices, and skilled nursing facilities. Suppliers include entities that furnish services primarily payable under Medicare Part B, such as independent diagnostic testing facilities, and durable medical equipment, prosthetics, and orthotics.
The new screening procedures would apply to newly enrolling providers and suppliers, including eligible professionals, beginning on March 23, 2011. The specific screenings would be performed based on the providers' or suppliers' level of risk--limited, moderate, or high. Limited refers to physician or non-physician practitioners and medical groups or clinics; moderate includes outpatient rehabilitation facilities and hospices; and high includes newly enrolling home health agencies or durable medical equipment suppliers.
The rules, which were proposed under the new healthcare reform law, are designed to reduce the estimated $55 billion in fraudulent or improper payments made annually by Medicare and Medicaid programs, according to administration officials.
In addition, House Ways and Means Health Subcommittee Chair Pete Stark (D-CA) and Rep. Wally Herger (R-CA), the panel's ranking member, introduced last week HR 6130, the Strengthening Medicare Anti-Fraud Measures Act. They were joined by 17 of their colleagues. The legislation expands the authority of the HHS' Office of Inspector General (OIG) to allow it to ban corporate executives from doing business with Medicare if their companies were convicted of fraud.
- NFP Hospitals' Revenue Growth at 'All-Time Low'
- CNO Leads $1M Charge for New Scrubs, Uniforms
- Transforming Cancer Care
- Acute Kidney Injury Gets New Focus
- Interventional Radiology No Longer a Sub-Specialty
- Sharp HealthCare Leaves Pioneer ACO Program
- Half of All Primary Care, Internal Medicine Jobs Unfilled in 2013
- mHealth Tackles Readmissions
- Proton Beam Therapy Poised for Growth in US
- MA an Insurance Proving Ground for Providers